Société Générale : The technical resistance should put an end to the rebound
| Entry price | Target | Stop-loss | Potential |
|---|
|
€31.64 |
€29.27 |
€33.4 |
+7.48% |
|---|
The recovery seen over the last trading sessions, should come to an end in the current trading zone due to the technical chart pattern for stocks in Société Générale.
Strengths● Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
● Its low valuation, with P/E ratio at 7.64 and 7.65 for the ongoing fiscal year and 2017 respectively, makes the stock pretty attractive with regard to earnings multiples.
● The company is one of the best yield companies with high dividend expectations.
● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
● According to Thomson-Reuters' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
● The company's earnings releases usually do not meet expectations.
● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
● The underlying tendency is negative on the weekly chart below the resistance at 36.95 EUR
© MarketScreener.com -
2016
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener India. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.
